Women Healthcare Global Market 2017: Key Players – Allergan plc, Amgen, Bayer A G, Becton Dickinson and Company, Eli Lilly Company, Merck & Co, Pfizer

Women Healthcare Market 2017

Global Women Healthcare Market Information; by Indication (Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer and others) by diagnosis and treatment; Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing and others), Treatment (Therapeutics, surgeries and others) by End users (Hospitals & Clinics, Gynecology Centers, Research Institutes, and others) - Forecast to 2023

Report Details:

This report provides in depth study of “Women Healthcare Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Women Healthcare Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

The market for women healthcare is projected to grow at a steady CAGR of 5.04% during the forecast period from 2017-2023.

Women health is referred to the health problems that are specific to women anatomy. It relates to the unique issues which includes pregnancy, menopause, and conditions of the female organs. Women health also includes medical situations in which women face problems not directly related to their biology but due to gender-differentiated access to medical treatment. Women's health issues have attained higher international perceptibility in the recent decades. The targeted policies and government initiatives to decrease the burden of the women health diseases have enabled women to lead healthier lives, while some significant gender-based health disparities remain in many countries. With limited awareness and less income levels in many developing countries are making health improvements for women exceptionally difficult.

Key Players for Women Healthcare Market:
Allergan plc. (Ireland)
Amgen (California)
Bayer A G (Germany)
Becton Dickinson and Company (U.S.)
Eli Lilly Company (U.S.)
Merck & Co., Inc., (U.S.)
Pfizer Inc., (U.S.)
Teva Pharmaceuticals (Israel).

Request for Sample Report @ https://www.marketresearchfuture.com/sample_request/3121 .

Market Segments:

The Women Healthcare Market is segmented on the basis of indications, diagnosis and treatment and also on the basis of end users. Based on the indications, the market has been segmented as postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer and others. Gynecologic cancer segment has been further divided into breast, ovarian or other types of cancer. On the basis of diagnosis the market has been segmented as bone densitometry, diagnostic imaging tests, biopsies, ovulation testing and others. Similarly, on the basis of treatment the market has been classified as therapeutics, surgeries and others. Lastly on the basis of end users the market has been further classified into hospitals & clinics, gynecology centers, research institutes, and others

Source:
WHO (World Health Organization), CDC (Centre for Disease Control and Prevention), Food and Drug Administration (FDA), NHS (National Health Services),Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Regional Analysis
On the basis of region the market is segmented into North America, Europe, Asia-Pacific and Middle East and Africa. North America was commands the largest market share which is expected to reach USD 21,782.6 million by 2023 due to well-developed economy and initiatives taken to promote women healthcare in the region. On the other hand factors such as high cost of diagnosis and treatments are restricting the market growth in the Middle East & African region, while Asia-Pacific countries are expected to be the fastest growing region with a CAGR of 5.46% from 2017-2023.

Complete Report Details@ https://www.marketresearchfuture.com/reports/women-healthcare-market-3121 .

Major Key Points in Table of Content:

1.Report Prologue
2.Market Introduction
3.Research Methodology

4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING POOR HEALTH CONDITIONS IS MAJOR CAUSE FOR FEMALE-SPECIFIC HEALTH ISSUES
4.2.2 GROWING EMPHASIS ON PREVENTIVE CARE SERVICES
4.2.3 INITIATIVES TAKEN TO PROMOTE WOMEN HEALTHCARE
4.2.4 INCREASE IN R&D ACTIVITIES BY MAJOR PLAYERS FOR WOMEN HEALTH
4.3 RESTRAINTS
4.3.1 HIGH COST OF DIAGNOSIS
4.3.2 HIGH COST OF TREATMENT
4.4 OPPORTUNITIES
4.4.1 EARLY DIAGNOSIS OF THE WOMEN HEALTH DISEASES
4.4.2 RISING AWARENESS FOR WOMEN HEALTH IN EMERGING NATIONS
4.5 CHALLENGE
4.5.1 CHALLENGES TO ACCESSING CARE
….

11 .COMPANY PROFILE
11.1 ALLERGAN PLC.
11.1.1 OVERVIEW
11.1.2 PRODUCT OVERVIEW
11.1.3 FINANCIALS
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.2 AMGEN
11.2.1 COMPANY OVERVIEW
11.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.2.3 FINANCIAL OVERVIEW
11.2.4 KEY DEVELOPMENT
11.2.5 SWOT ANALYSIS
11.3 BAYER AG
11.3.1 OVERVIEW
11.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.3.3 FINANCIAL UPDATES
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.4 BECTON, DICKINSON AND COMPANY
11.4.1 OVERVIEW
11.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.4.3 FINANCIAL UPDATES
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.5 ELI LILLY COMPANY
11.5.1 COMPANY OVERVIEW
11.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
11.5.3 FINANCIAL OVERVIEW
11.5.4 KEY DEVELOPMENT
11.5.5 SWOT ANALYSIS
11.6 MERCK & CO., INC.
11.6.1 OVERVIEW
11.6.2 PRODUCT OVERVIEW
11.6.3 FINANCIALS
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.7 PFIZER INC.
11.7.1 OVERVIEW
11.7.2 PRODUCT OVERVIEW
11.7.3 FINANCIALS
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS

CONTINUED...

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.